Engaging Innovation | Friends of Cancer Research

Engaging Innovation

Featured Post

December 10, 2018

Friends of Cancer Research Annual Meeting 2018

This year’s Friends of Cancer Research (Friends) Annual Meeting started with a morning keynote by Anna Abram the Deputy Commissioner for Policy, Planning, Legislation and Analysis at the U.S. Food and Drug Administration (FDA). Abram discussed many different initiatives that have been led by Friends over the years including the...
More Posts

Recent Posts

No Results With Current Filter Choices

A Plea to Make Cancer Clinical Trials More Patient Friendly

Jim Omel is a myeloma patient and a cancer research advocate. He spoke at the 2017 Friends of Cancer Research Annual Meeting and was an author of the panel 2 whitepaper, Data Generation to Support Cross-Labeling of Indications for Combination Products. Below are his abridged remarks from the meeting. To...

Keeping Patients at the Forefront of Our Work

I was 18 when my life was turned upside down by cancer. My mother was diagnosed with a highly aggressive malignancy after a colonoscopy due to a flair-up of Crohn’s disease. She spent the next two months in the hospital after the surgery to remove the malignancy left her near...

Ellen Sigal Talks About Collaboration in Lung-MAP

Friends of Cancer Research Chairperson & Founder, Ellen Sigal, discusses the structure and promise of the Lung-MAP clinical trial.

My Story: Stephanie Haney

Stephanie and her family were shocked by her diagnosis. She had no risk factors or family history. With the help of newly available treatments, such as breakthrough therapies, she has defied the odds.

My Story: Stephanie Haney

Stephanie and her family were shocked by her diagnosis. She had no risk factors or family history. With the help of newly available treatments, such as breakthrough therapies, she has defied the odds.

My Story: Stephanie Haney

Stephanie and her family were shocked by her diagnosis. She had no risk factors or family history. With the help of newly available treatments, such as breakthrough therapies, she has defied the odds.

My Story: Stephanie Haney

Stephanie and her family were shocked by her diagnosis. She had no risk factors or family history. With the help of newly available treatments, such as breakthrough therapies, she has defied the odds.

Back to Top